READ THE EVIDENCE, NOT THE HYPE.
SCIENCE
LIBRARY.
We separate human clinical evidence from animal, cellular, and mechanistic research so you can see what is known, what is promising, and what remains unanswered.
Controlled or observational research involving people.
Animal or cell research—not proof of a human outcome.
Explains a biological pathway, not a demonstrated benefit.
TRIPLE-RECEPTOR
RESEARCH
Retatrutide is a single investigational molecule designed to activate three nutrient-responsive hormone receptors: GIP, GLP-1, and glucagon.
Explore RETA science →Glucose-dependent insulinotropic polypeptide
Studied for its role in nutrient signaling and glucose-dependent insulin response.
Glucagon-like peptide-1
Studied in appetite signaling, gastric emptying, and glucose-dependent insulin secretion.
Glucagon receptor
Studied for roles in hepatic energy metabolism and energy expenditure.
THREE RESEARCH
PATHWAYS
GLOW combines GHK-Cu, BPC-157, and TB-500. The combined blend itself has not been established in human clinical trials.
Explore GLOW science →GHK-Cu
Studied in cellular signaling, collagen-related pathways, inflammation, and tissue repair models.
BPC-157
Most published findings are animal studies. Reviews find major gaps in human safety, dosing, and efficacy data.
TB-500 / Thymosin β4 research
Thymosin β4 has been studied in cell and animal models of migration, angiogenesis, and wound repair. TB-500 products are not established human therapies.